Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism

Cell Death and Differentiation

Volumn 23, Issue 1, 2016, Pages 123-131

  Lemarchand, E ^a   Maubert, E ^a   Haelewyn, B ^a   Ali, C ^a   Rubio, M ^a   Vivien, D ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; EGFR PROTEIN, MOUSE; GLUCOSE; OXYGEN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; HEART ARREST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPAL SLICE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL DEATH; CENTRAL NERVOUS SYSTEM; GENETICS; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CENTRAL NERVOUS SYSTEM; GLUCOSE; HIPPOCAMPUS; MICE; NEURONS; OXYGEN; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84949534555     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.76     Document Type: Article

References (47)

1. Rijken DC, Sakharov DV. Basic principles in thrombolysis: regulatory role of plasminogen. Thromb Res 2001; 103: S41-S49.
2. Docagne F, Parcq J, Lijnen R, AliC, Vivien D. Understanding the functions of endogenous and exogenous tissue-Type plasminogen activator during stroke. Stroke 46: 314-320.
3. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 1998; 21: 813-825.
4. Kim YH, Park JH, Hong SH, Koh JY. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 1999; 284: 647-650.
5. Tsirka SE, Rogove AD, Strickland S. Neuronal cell death and tPA. Nature 1996; 384: 123-124.
6. Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P., et al. Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med 2011; 208: 1229-1242.
7. Fredriksson L, Ehnman M, Fieber C, Eriksson U. Structural requirements for activation of latent platelet-Derived growth factor CC by tissue plasminogen activator. J Biol Chem 2005; 280: 26856-26862.
8. Samson AL, Nevin ST, Croucher D, Niego B, Daniel PB, Weiss TW., et al. Tissue-Type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem 2008; 107: 1091-1101.
9. Siao CJ, Tsirka SE. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 2002; 22: 3352-3358.
10. Yao Y, Tsirka SE. Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption. J Cell Sci 2011; 124: 1486-1495.
11. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET., et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001; 7: 59-64.
12. Mantuano E, Lam MS, Gonias SL. LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-Type plasminogen activator and myelin-Associated glycoprotein. J Biol Chem 2013; 288: 34009-34018.
13. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-Type and tPAdeficient mice. Nat Med 1998; 4: 228-231.
14. Benchenane K, Castel H, Boulouard M, Bluthe R, Fernandez-Monreal M, Roussel BD., et al. Anti-NR1 N-Terminal-Domain vaccination unmasks the crucial action of tPA on NMDAreceptor-mediated toxicity and spatial memory. J Cell Sci 2007; 120: 578-585.
15. Lopez-Atalaya JP, Roussel BD, Levrat D, Parcq J, Nicole O, Hommet Y., et al. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. J Cereb Blood Flow Metab 2008; 28: 1212-1221.
16. Martin AM, Kuhlmann C, Trossbach S, Jaeger S,Waldron E, Roebroek A., et al. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-Type plasminogen activatormediated activation of N-methyl-D-Aspartate receptors. J Biol Chem 2008; 283: 12004-12013.
17. Liot G, Roussel BD, Lebeurrier N, Benchenane K, Lopez-Atalaya JP, Vivien D., et al. Tissuetype plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity. J Neurochem 2006; 98: 1458-1464.
18. Lee HY, Hwang IY, Im H, Koh JY, Kim YH. Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons. J Neurochem 2007; 101: 1236-1247.
19. Echeverry R, Wu J, Haile WB, Guzman J, Yepes M. Tissue-Type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest 2010; 120: 2194-2205.
20. Wu F, Nicholson AD, Haile WB, Torre E, An J, Chen C., et al. Tissue-Type plasminogen activator mediates neuronal detection and adaptation to metabolic stress. J Cereb Blood Flow Metab 2013; 33: 1761-1769.
21. Tsirka SE, Gualandris A, Amaral DG, Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995; 377: 340-344.
22. Wu F, Echeverry R, Wu J, An J, Haile WB, Cooper DS., et al. Tissue-Type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway. Mol Cell Neurosci 2013; 52: 9-19.
23. Montagne A, Hebert M, Jullienne A, Lesept F, Le Behot A, Louessard M., et al. Memantine improves safety of thrombolysis for stroke. Stroke 2012; 43: 2774-2781.
24. Hendrickx HH, Rao GR, Safar P, Gisvold SE. Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. Resuscitation 1984; 12: 97-116.
25. Unal-Cevik I, Kilin M, Gürsoy-Ozdemir Y, Gurer G, Dalkara T. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res 2004; 1015: 169-174.
26. Pringle AK, Iannotti F, Wilde GJ, Chad JE, Seeley PJ, Sundstrom LE. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res 1997; 755: 36-46.
27. Macrez R, Bezin L, Le Mauff B, Ali C, Vivien D. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-Aspartate receptors during stroke. Stroke 2010; 41: 2950-2955.
28. Bu G, Schwartz AL. RAP, a novel type of ER chaperone. Trends Cell Biol 1998; 8: 272-276.
29. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996; 379: 557-560.
30. Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J., et al. Antibodies preventing the interaction of tissue-Type plasminogen activator with N-methyl-D-Aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis. Stroke 2011; 42: 2315-2322.
31. An J, Zhang C, Polavarapu R, Zhang X, Yepes M. Tissue-Type plasminogen activator and the low-Density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 2008; 112: 2787-2794.
32. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-Type plasminogen activator induces opening of the blood-brain barrier via the LDL receptorrelated protein. J Clin Invest 2003; 112: 1533-1540.
33. Carrillo-Garcia C, Prochnow S, Simeonova IK, Strelau J, Hölzl-Wenig G, Mandl C., et al. Growth/differentiation factor 15 promotes EGFR signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice. Development 2014; 141: 773-783.
34. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D. Tissue-plasminogen activator is induced as an immediate-Early gene during seizure, kindling and long-Term potentiation. Nature 1993; 361: 453-457.
35. Hashimoto T, Kajii Y, Nishikawa T. Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. Eur J Neurosci 1998; 10: 3387-3399.
36. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
37. Alvarez V, Rossetti AO, Papavasileiou V, Michel P. Acute seizures in acute ischemic stroke: does thrombolysis have a role to play?. J Neurol 2013; 260: 55-61.
38. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL., et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-Analysis. Lancet 2012; 379: 2364-2372.
39. Flavin MP, Zhao G. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury. J Neurosci Res 2001; 63: 388-394.
40. Wu F, Wu J, Nicholson AD, Echeverry R, Haile WB, Catano M., et al. Tissue-Type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain. J Neurosci 2012; 32: 9848-9858.
41. Takahashi H, Nagai N, Urano T. Role of tissue plasminogen activator/plasmin cascade in delayed neuronal death after transient forebrain ischemia. Neurosci Lett 2005; 381: 189-193.
42. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37: 173-182.
43. Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L., et al. Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 2009; 132: 2219-2230.
44. Angles-Cano E. A spectrophotometric solid-phase fibrin-Tissue plasminogen activator activity assay (SOFIA-TPA) for high-fibrin-Affinity tissue plasminogen activators. Anal Biochem 1986; 153: 201-210.
45. Boutière B, Arnoux D, Benchimol P, Sampol J, Risède P, Angles-Cano E. Solid-phase fibrintissue-plasminogen-Activator activity assay (SOFIA-TPA): tPA but not UK is specifically detected. Thromb Res 1986; 43: 129-132.
46. Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Angles-Cano E. Molecular assembly of plasminogen and tissue-Type plasminogen activator on an evolving fibrin surface. Eur J Biochem 1993; 216: 549-556.
47. Longstaff C, Thelwell C, Williams SC, Silva MM, Szabo L, Kolev K. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies. Blood 2011; 117: 661-668.